Report Overview
Neglected tropical diseases (NTDs) are a diverse group of tropical infections which are common in low-income populations in developing regions of Africa, Asia, and the Americas. They are caused by a variety of pathogens such as viruses, bacteria, protozoa and helminths.
The global Neglected Tropical Diseases Drugs and Vaccine market size was estimated at USD 345 million in 2023 and is projected to reach USD 517.14 million by 2032, exhibiting a CAGR of 4.60% during the forecast period.
North America Neglected Tropical Diseases Drugs and Vaccine market size was estimated at USD 97.13 million in 2023, at a CAGR of 3.94% during the forecast period of 2025 through 2032.
This report provides a deep insight into the global Neglected Tropical Diseases Drugs and Vaccine market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Neglected Tropical Diseases Drugs and Vaccine Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Neglected Tropical Diseases Drugs and Vaccine market in any manner.
Global Neglected Tropical Diseases Drugs and Vaccine Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Artecef BV
GlaxoSmithKline
AstraZeneca
Novartis
Sanofi-Aventis
Ranbaxy Labs
Lupin
Macleods Pharmaceuticals
Cipla
Romark Laboratories
Toyama Chemica
Market Segmentation (by Type)
Malaria
Ebola
Dengue
Chagas
Leishmaniasis
Other
Market Segmentation (by Application)
Drugs
Vaccines
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Neglected Tropical Diseases Drugs and Vaccine Market
Overview of the regional outlook of the Neglected Tropical Diseases Drugs and Vaccine Market:
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Neglected Tropical Diseases Drugs and Vaccine
1.2 Key Market Segments
1.2.1 Neglected Tropical Diseases Drugs and Vaccine Segment by Type
1.2.2 Neglected Tropical Diseases Drugs and Vaccine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Neglected Tropical Diseases Drugs and Vaccine Market Overview
2.1 Global Market Overview
2.1.1 Global Neglected Tropical Diseases Drugs and Vaccine Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Neglected Tropical Diseases Drugs and Vaccine Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Neglected Tropical Diseases Drugs and Vaccine Market Competitive Landscape
3.1 Global Neglected Tropical Diseases Drugs and Vaccine Sales by Manufacturers (2019-2025)
3.2 Global Neglected Tropical Diseases Drugs and Vaccine Revenue Market Share by Manufacturers (2019-2025)
3.3 Neglected Tropical Diseases Drugs and Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Neglected Tropical Diseases Drugs and Vaccine Average Price by Manufacturers (2019-2025)
3.5 Manufacturers Neglected Tropical Diseases Drugs and Vaccine Sales Sites, Area Served, Product Type
3.6 Neglected Tropical Diseases Drugs and Vaccine Market Competitive Situation and Trends
3.6.1 Neglected Tropical Diseases Drugs and Vaccine Market Concentration Rate
3.6.2 Global 5 and 10 Largest Neglected Tropical Diseases Drugs and Vaccine Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Neglected Tropical Diseases Drugs and Vaccine Industry Chain Analysis
4.1 Neglected Tropical Diseases Drugs and Vaccine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Neglected Tropical Diseases Drugs and Vaccine Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Neglected Tropical Diseases Drugs and Vaccine Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Neglected Tropical Diseases Drugs and Vaccine Sales Market Share by Type (2019-2025)
6.3 Global Neglected Tropical Diseases Drugs and Vaccine Market Size Market Share by Type (2019-2025)
6.4 Global Neglected Tropical Diseases Drugs and Vaccine Price by Type (2019-2025)
7 Neglected Tropical Diseases Drugs and Vaccine Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Neglected Tropical Diseases Drugs and Vaccine Market Sales by Application (2019-2025)
7.3 Global Neglected Tropical Diseases Drugs and Vaccine Market Size (M USD) by Application (2019-2025)
7.4 Global Neglected Tropical Diseases Drugs and Vaccine Sales Growth Rate by Application (2019-2025)
8 Neglected Tropical Diseases Drugs and Vaccine Market Consumption by Region
8.1 Global Neglected Tropical Diseases Drugs and Vaccine Sales by Region
8.1.1 Global Neglected Tropical Diseases Drugs and Vaccine Sales by Region
8.1.2 Global Neglected Tropical Diseases Drugs and Vaccine Sales Market Share by Region
8.2 North America
8.2.1 North America Neglected Tropical Diseases Drugs and Vaccine Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Neglected Tropical Diseases Drugs and Vaccine Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Neglected Tropical Diseases Drugs and Vaccine Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Neglected Tropical Diseases Drugs and Vaccine Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Neglected Tropical Diseases Drugs and Vaccine Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Neglected Tropical Diseases Drugs and Vaccine Market Production by Region
9.1 Global Production of Neglected Tropical Diseases Drugs and Vaccine by Region (2019-2025)
9.2 Global Neglected Tropical Diseases Drugs and Vaccine Revenue Market Share by Region (2019-2025)
9.3 Global Neglected Tropical Diseases Drugs and Vaccine Production, Revenue, Price and Gross Margin (2019-2025)
9.4 North America Neglected Tropical Diseases Drugs and Vaccine Production
9.4.1 North America Neglected Tropical Diseases Drugs and Vaccine Production Growth Rate (2019-2025)
9.4.2 North America Neglected Tropical Diseases Drugs and Vaccine Production, Revenue, Price and Gross Margin (2019-2025)
9.5 Europe Neglected Tropical Diseases Drugs and Vaccine Production
9.5.1 Europe Neglected Tropical Diseases Drugs and Vaccine Production Growth Rate (2019-2025)
9.5.2 Europe Neglected Tropical Diseases Drugs and Vaccine Production, Revenue, Price and Gross Margin (2019-2025)
9.6 Japan Neglected Tropical Diseases Drugs and Vaccine Production (2019-2025)
9.6.1 Japan Neglected Tropical Diseases Drugs and Vaccine Production Growth Rate (2019-2025)
9.6.2 Japan Neglected Tropical Diseases Drugs and Vaccine Production, Revenue, Price and Gross Margin (2019-2025)
9.7 China Neglected Tropical Diseases Drugs and Vaccine Production (2019-2025)
9.7.1 China Neglected Tropical Diseases Drugs and Vaccine Production Growth Rate (2019-2025)
9.7.2 China Neglected Tropical Diseases Drugs and Vaccine Production, Revenue, Price and Gross Margin (2019-2025)
10 Key Companies Profile
10.1 Artecef BV
10.1.1 Artecef BV Neglected Tropical Diseases Drugs and Vaccine Basic Information
10.1.2 Artecef BV Neglected Tropical Diseases Drugs and Vaccine Product Overview
10.1.3 Artecef BV Neglected Tropical Diseases Drugs and Vaccine Product Market Performance
10.1.4 Artecef BV Business Overview
10.1.5 Artecef BV Neglected Tropical Diseases Drugs and Vaccine SWOT Analysis
10.1.6 Artecef BV Recent Developments
10.2 GlaxoSmithKline
10.2.1 GlaxoSmithKline Neglected Tropical Diseases Drugs and Vaccine Basic Information
10.2.2 GlaxoSmithKline Neglected Tropical Diseases Drugs and Vaccine Product Overview
10.2.3 GlaxoSmithKline Neglected Tropical Diseases Drugs and Vaccine Product Market Performance
10.2.4 GlaxoSmithKline Business Overview
10.2.5 GlaxoSmithKline Neglected Tropical Diseases Drugs and Vaccine SWOT Analysis
10.2.6 GlaxoSmithKline Recent Developments
10.3 AstraZeneca
10.3.1 AstraZeneca Neglected Tropical Diseases Drugs and Vaccine Basic Information
10.3.2 AstraZeneca Neglected Tropical Diseases Drugs and Vaccine Product Overview
10.3.3 AstraZeneca Neglected Tropical Diseases Drugs and Vaccine Product Market Performance
10.3.4 AstraZeneca Neglected Tropical Diseases Drugs and Vaccine SWOT Analysis
10.3.5 AstraZeneca Business Overview
10.3.6 AstraZeneca Recent Developments
10.4 Novartis
10.4.1 Novartis Neglected Tropical Diseases Drugs and Vaccine Basic Information
10.4.2 Novartis Neglected Tropical Diseases Drugs and Vaccine Product Overview
10.4.3 Novartis Neglected Tropical Diseases Drugs and Vaccine Product Market Performance
10.4.4 Novartis Business Overview
10.4.5 Novartis Recent Developments
10.5 Sanofi-Aventis
10.5.1 Sanofi-Aventis Neglected Tropical Diseases Drugs and Vaccine Basic Information
10.5.2 Sanofi-Aventis Neglected Tropical Diseases Drugs and Vaccine Product Overview
10.5.3 Sanofi-Aventis Neglected Tropical Diseases Drugs and Vaccine Product Market Performance
10.5.4 Sanofi-Aventis Business Overview
10.5.5 Sanofi-Aventis Recent Developments
10.6 Ranbaxy Labs
10.6.1 Ranbaxy Labs Neglected Tropical Diseases Drugs and Vaccine Basic Information
10.6.2 Ranbaxy Labs Neglected Tropical Diseases Drugs and Vaccine Product Overview
10.6.3 Ranbaxy Labs Neglected Tropical Diseases Drugs and Vaccine Product Market Performance
10.6.4 Ranbaxy Labs Business Overview
10.6.5 Ranbaxy Labs Recent Developments
10.7 Lupin
10.7.1 Lupin Neglected Tropical Diseases Drugs and Vaccine Basic Information
10.7.2 Lupin Neglected Tropical Diseases Drugs and Vaccine Product Overview
10.7.3 Lupin Neglected Tropical Diseases Drugs and Vaccine Product Market Performance
10.7.4 Lupin Business Overview
10.7.5 Lupin Recent Developments
10.8 Macleods Pharmaceuticals
10.8.1 Macleods Pharmaceuticals Neglected Tropical Diseases Drugs and Vaccine Basic Information
10.8.2 Macleods Pharmaceuticals Neglected Tropical Diseases Drugs and Vaccine Product Overview
10.8.3 Macleods Pharmaceuticals Neglected Tropical Diseases Drugs and Vaccine Product Market Performance
10.8.4 Macleods Pharmaceuticals Business Overview
10.8.5 Macleods Pharmaceuticals Recent Developments
10.9 Cipla
10.9.1 Cipla Neglected Tropical Diseases Drugs and Vaccine Basic Information
10.9.2 Cipla Neglected Tropical Diseases Drugs and Vaccine Product Overview
10.9.3 Cipla Neglected Tropical Diseases Drugs and Vaccine Product Market Performance
10.9.4 Cipla Business Overview
10.9.5 Cipla Recent Developments
10.10 Romark Laboratories
10.10.1 Romark Laboratories Neglected Tropical Diseases Drugs and Vaccine Basic Information
10.10.2 Romark Laboratories Neglected Tropical Diseases Drugs and Vaccine Product Overview
10.10.3 Romark Laboratories Neglected Tropical Diseases Drugs and Vaccine Product Market Performance
10.10.4 Romark Laboratories Business Overview
10.10.5 Romark Laboratories Recent Developments
10.11 Toyama Chemica
10.11.1 Toyama Chemica Neglected Tropical Diseases Drugs and Vaccine Basic Information
10.11.2 Toyama Chemica Neglected Tropical Diseases Drugs and Vaccine Product Overview
10.11.3 Toyama Chemica Neglected Tropical Diseases Drugs and Vaccine Product Market Performance
10.11.4 Toyama Chemica Business Overview
10.11.5 Toyama Chemica Recent Developments
11 Neglected Tropical Diseases Drugs and Vaccine Market Forecast by Region
11.1 Global Neglected Tropical Diseases Drugs and Vaccine Market Size Forecast
11.2 Global Neglected Tropical Diseases Drugs and Vaccine Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Neglected Tropical Diseases Drugs and Vaccine Market Size Forecast by Country
11.2.3 Asia Pacific Neglected Tropical Diseases Drugs and Vaccine Market Size Forecast by Region
11.2.4 South America Neglected Tropical Diseases Drugs and Vaccine Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of Neglected Tropical Diseases Drugs and Vaccine by Country
12 Forecast Market by Type and by Application (2025-2032)
12.1 Global Neglected Tropical Diseases Drugs and Vaccine Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Neglected Tropical Diseases Drugs and Vaccine by Type (2025-2032)
12.1.2 Global Neglected Tropical Diseases Drugs and Vaccine Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Neglected Tropical Diseases Drugs and Vaccine by Type (2025-2032)
12.2 Global Neglected Tropical Diseases Drugs and Vaccine Market Forecast by Application (2025-2032)
12.2.1 Global Neglected Tropical Diseases Drugs and Vaccine Sales (K MT) Forecast by Application
12.2.2 Global Neglected Tropical Diseases Drugs and Vaccine Market Size (M USD) Forecast by Application (2025-2032)
13 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Neglected Tropical Diseases Drugs and Vaccine Market Size Comparison by Region (M USD)
Table 5. Global Neglected Tropical Diseases Drugs and Vaccine Sales (K MT) by Manufacturers (2019-2025)
Table 6. Global Neglected Tropical Diseases Drugs and Vaccine Sales Market Share by Manufacturers (2019-2025)
Table 7. Global Neglected Tropical Diseases Drugs and Vaccine Revenue (M USD) by Manufacturers (2019-2025)
Table 8. Global Neglected Tropical Diseases Drugs and Vaccine Revenue Share by Manufacturers (2019-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neglected Tropical Diseases Drugs and Vaccine as of 2022)
Table 10. Global Market Neglected Tropical Diseases Drugs and Vaccine Average Price (USD/MT) of Key Manufacturers (2019-2025)
Table 11. Manufacturers Neglected Tropical Diseases Drugs and Vaccine Sales Sites and Area Served
Table 12. Manufacturers Neglected Tropical Diseases Drugs and Vaccine Product Type
Table 13. Global Neglected Tropical Diseases Drugs and Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Neglected Tropical Diseases Drugs and Vaccine
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Neglected Tropical Diseases Drugs and Vaccine Market Challenges
Table 22. Global Neglected Tropical Diseases Drugs and Vaccine Sales by Type (K MT)
Table 23. Global Neglected Tropical Diseases Drugs and Vaccine Market Size by Type (M USD)
Table 24. Global Neglected Tropical Diseases Drugs and Vaccine Sales (K MT) by Type (2019-2025)
Table 25. Global Neglected Tropical Diseases Drugs and Vaccine Sales Market Share by Type (2019-2025)
Table 26. Global Neglected Tropical Diseases Drugs and Vaccine Market Size (M USD) by Type (2019-2025)
Table 27. Global Neglected Tropical Diseases Drugs and Vaccine Market Size Share by Type (2019-2025)
Table 28. Global Neglected Tropical Diseases Drugs and Vaccine Price (USD/MT) by Type (2019-2025)
Table 29. Global Neglected Tropical Diseases Drugs and Vaccine Sales (K MT) by Application
Table 30. Global Neglected Tropical Diseases Drugs and Vaccine Market Size by Application
Table 31. Global Neglected Tropical Diseases Drugs and Vaccine Sales by Application (2019-2025) & (K MT)
Table 32. Global Neglected Tropical Diseases Drugs and Vaccine Sales Market Share by Application (2019-2025)
Table 33. Global Neglected Tropical Diseases Drugs and Vaccine Sales by Application (2019-2025) & (M USD)
Table 34. Global Neglected Tropical Diseases Drugs and Vaccine Market Share by Application (2019-2025)
Table 35. Global Neglected Tropical Diseases Drugs and Vaccine Sales Growth Rate by Application (2019-2025)
Table 36. Global Neglected Tropical Diseases Drugs and Vaccine Sales by Region (2019-2025) & (K MT)
Table 37. Global Neglected Tropical Diseases Drugs and Vaccine Sales Market Share by Region (2019-2025)
Table 38. North America Neglected Tropical Diseases Drugs and Vaccine Sales by Country (2019-2025) & (K MT)
Table 39. Europe Neglected Tropical Diseases Drugs and Vaccine Sales by Country (2019-2025) & (K MT)
Table 40. Asia Pacific Neglected Tropical Diseases Drugs and Vaccine Sales by Region (2019-2025) & (K MT)
Table 41. South America Neglected Tropical Diseases Drugs and Vaccine Sales by Country (2019-2025) & (K MT)
Table 42. Middle East and Africa Neglected Tropical Diseases Drugs and Vaccine Sales by Region (2019-2025) & (K MT)
Table 43. Global Neglected Tropical Diseases Drugs and Vaccine Production (K MT) by Region (2019-2025)
Table 44. Global Neglected Tropical Diseases Drugs and Vaccine Revenue (US$ Million) by Region (2019-2025)
Table 45. Global Neglected Tropical Diseases Drugs and Vaccine Revenue Market Share by Region (2019-2025)
Table 46. Global Neglected Tropical Diseases Drugs and Vaccine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 47. North America Neglected Tropical Diseases Drugs and Vaccine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 48. Europe Neglected Tropical Diseases Drugs and Vaccine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 49. Japan Neglected Tropical Diseases Drugs and Vaccine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 50. China Neglected Tropical Diseases Drugs and Vaccine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 51. Artecef BV Neglected Tropical Diseases Drugs and Vaccine Basic Information
Table 52. Artecef BV Neglected Tropical Diseases Drugs and Vaccine Product Overview
Table 53. Artecef BV Neglected Tropical Diseases Drugs and Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 54. Artecef BV Business Overview
Table 55. Artecef BV Neglected Tropical Diseases Drugs and Vaccine SWOT Analysis
Table 56. Artecef BV Recent Developments
Table 57. GlaxoSmithKline Neglected Tropical Diseases Drugs and Vaccine Basic Information
Table 58. GlaxoSmithKline Neglected Tropical Diseases Drugs and Vaccine Product Overview
Table 59. GlaxoSmithKline Neglected Tropical Diseases Drugs and Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 60. GlaxoSmithKline Business Overview
Table 61. GlaxoSmithKline Neglected Tropical Diseases Drugs and Vaccine SWOT Analysis
Table 62. GlaxoSmithKline Recent Developments
Table 63. AstraZeneca Neglected Tropical Diseases Drugs and Vaccine Basic Information
Table 64. AstraZeneca Neglected Tropical Diseases Drugs and Vaccine Product Overview
Table 65. AstraZeneca Neglected Tropical Diseases Drugs and Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 66. AstraZeneca Neglected Tropical Diseases Drugs and Vaccine SWOT Analysis
Table 67. AstraZeneca Business Overview
Table 68. AstraZeneca Recent Developments
Table 69. Novartis Neglected Tropical Diseases Drugs and Vaccine Basic Information
Table 70. Novartis Neglected Tropical Diseases Drugs and Vaccine Product Overview
Table 71. Novartis Neglected Tropical Diseases Drugs and Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 72. Novartis Business Overview
Table 73. Novartis Recent Developments
Table 74. Sanofi-Aventis Neglected Tropical Diseases Drugs and Vaccine Basic Information
Table 75. Sanofi-Aventis Neglected Tropical Diseases Drugs and Vaccine Product Overview
Table 76. Sanofi-Aventis Neglected Tropical Diseases Drugs and Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 77. Sanofi-Aventis Business Overview
Table 78. Sanofi-Aventis Recent Developments
Table 79. Ranbaxy Labs Neglected Tropical Diseases Drugs and Vaccine Basic Information
Table 80. Ranbaxy Labs Neglected Tropical Diseases Drugs and Vaccine Product Overview
Table 81. Ranbaxy Labs Neglected Tropical Diseases Drugs and Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 82. Ranbaxy Labs Business Overview
Table 83. Ranbaxy Labs Recent Developments
Table 84. Lupin Neglected Tropical Diseases Drugs and Vaccine Basic Information
Table 85. Lupin Neglected Tropical Diseases Drugs and Vaccine Product Overview
Table 86. Lupin Neglected Tropical Diseases Drugs and Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 87. Lupin Business Overview
Table 88. Lupin Recent Developments
Table 89. Macleods Pharmaceuticals Neglected Tropical Diseases Drugs and Vaccine Basic Information
Table 90. Macleods Pharmaceuticals Neglected Tropical Diseases Drugs and Vaccine Product Overview
Table 91. Macleods Pharmaceuticals Neglected Tropical Diseases Drugs and Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 92. Macleods Pharmaceuticals Business Overview
Table 93. Macleods Pharmaceuticals Recent Developments
Table 94. Cipla Neglected Tropical Diseases Drugs and Vaccine Basic Information
Table 95. Cipla Neglected Tropical Diseases Drugs and Vaccine Product Overview
Table 96. Cipla Neglected Tropical Diseases Drugs and Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 97. Cipla Business Overview
Table 98. Cipla Recent Developments
Table 99. Romark Laboratories Neglected Tropical Diseases Drugs and Vaccine Basic Information
Table 100. Romark Laboratories Neglected Tropical Diseases Drugs and Vaccine Product Overview
Table 101. Romark Laboratories Neglected Tropical Diseases Drugs and Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 102. Romark Laboratories Business Overview
Table 103. Romark Laboratories Recent Developments
Table 104. Toyama Chemica Neglected Tropical Diseases Drugs and Vaccine Basic Information
Table 105. Toyama Chemica Neglected Tropical Diseases Drugs and Vaccine Product Overview
Table 106. Toyama Chemica Neglected Tropical Diseases Drugs and Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 107. Toyama Chemica Business Overview
Table 108. Toyama Chemica Recent Developments
Table 109. Global Neglected Tropical Diseases Drugs and Vaccine Sales Forecast by Region (2025-2032) & (K MT)
Table 110. Global Neglected Tropical Diseases Drugs and Vaccine Market Size Forecast by Region (2025-2032) & (M USD)
Table 111. North America Neglected Tropical Diseases Drugs and Vaccine Sales Forecast by Country (2025-2032) & (K MT)
Table 112. North America Neglected Tropical Diseases Drugs and Vaccine Market Size Forecast by Country (2025-2032) & (M USD)
Table 113. Europe Neglected Tropical Diseases Drugs and Vaccine Sales Forecast by Country (2025-2032) & (K MT)
Table 114. Europe Neglected Tropical Diseases Drugs and Vaccine Market Size Forecast by Country (2025-2032) & (M USD)
Table 115. Asia Pacific Neglected Tropical Diseases Drugs and Vaccine Sales Forecast by Region (2025-2032) & (K MT)
Table 116. Asia Pacific Neglected Tropical Diseases Drugs and Vaccine Market Size Forecast by Region (2025-2032) & (M USD)
Table 117. South America Neglected Tropical Diseases Drugs and Vaccine Sales Forecast by Country (2025-2032) & (K MT)
Table 118. South America Neglected Tropical Diseases Drugs and Vaccine Market Size Forecast by Country (2025-2032) & (M USD)
Table 119. Middle East and Africa Neglected Tropical Diseases Drugs and Vaccine Consumption Forecast by Country (2025-2032) & (Units)
Table 120. Middle East and Africa Neglected Tropical Diseases Drugs and Vaccine Market Size Forecast by Country (2025-2032) & (M USD)
Table 121. Global Neglected Tropical Diseases Drugs and Vaccine Sales Forecast by Type (2025-2032) & (K MT)
Table 122. Global Neglected Tropical Diseases Drugs and Vaccine Market Size Forecast by Type (2025-2032) & (M USD)
Table 123. Global Neglected Tropical Diseases Drugs and Vaccine Price Forecast by Type (2025-2032) & (USD/MT)
Table 124. Global Neglected Tropical Diseases Drugs and Vaccine Sales (K MT) Forecast by Application (2025-2032)
Table 125. Global Neglected Tropical Diseases Drugs and Vaccine Market Size Forecast by Application (2025-2032) & (M USD)
List of Figures
Figure 1. Product Picture of Neglected Tropical Diseases Drugs and Vaccine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Neglected Tropical Diseases Drugs and Vaccine Market Size (M USD), 2019-2032
Figure 5. Global Neglected Tropical Diseases Drugs and Vaccine Market Size (M USD) (2019-2032)
Figure 6. Global Neglected Tropical Diseases Drugs and Vaccine Sales (K MT) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (M USD)
Figure 11. Neglected Tropical Diseases Drugs and Vaccine Sales Share by Manufacturers in 2023
Figure 12. Global Neglected Tropical Diseases Drugs and Vaccine Revenue Share by Manufacturers in 2023
Figure 13. Neglected Tropical Diseases Drugs and Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Neglected Tropical Diseases Drugs and Vaccine Average Price (USD/MT) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Neglected Tropical Diseases Drugs and Vaccine Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Neglected Tropical Diseases Drugs and Vaccine Market Share by Type
Figure 18. Sales Market Share of Neglected Tropical Diseases Drugs and Vaccine by Type (2019-2025)
Figure 19. Sales Market Share of Neglected Tropical Diseases Drugs and Vaccine by Type in 2023
Figure 20. Market Size Share of Neglected Tropical Diseases Drugs and Vaccine by Type (2019-2025)
Figure 21. Market Size Market Share of Neglected Tropical Diseases Drugs and Vaccine by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Neglected Tropical Diseases Drugs and Vaccine Market Share by Application
Figure 24. Global Neglected Tropical Diseases Drugs and Vaccine Sales Market Share by Application (2019-2025)
Figure 25. Global Neglected Tropical Diseases Drugs and Vaccine Sales Market Share by Application in 2023
Figure 26. Global Neglected Tropical Diseases Drugs and Vaccine Market Share by Application (2019-2025)
Figure 27. Global Neglected Tropical Diseases Drugs and Vaccine Market Share by Application in 2023
Figure 28. Global Neglected Tropical Diseases Drugs and Vaccine Sales Growth Rate by Application (2019-2025)
Figure 29. Global Neglected Tropical Diseases Drugs and Vaccine Sales Market Share by Region (2019-2025)
Figure 30. North America Neglected Tropical Diseases Drugs and Vaccine Sales and Growth Rate (2019-2025) & (K MT)
Figure 31. North America Neglected Tropical Diseases Drugs and Vaccine Sales Market Share by Country in 2023
Figure 32. U.S. Neglected Tropical Diseases Drugs and Vaccine Sales and Growth Rate (2019-2025) & (K MT)
Figure 33. Canada Neglected Tropical Diseases Drugs and Vaccine Sales (K MT) and Growth Rate (2019-2025)
Figure 34. Mexico Neglected Tropical Diseases Drugs and Vaccine Sales (Units) and Growth Rate (2019-2025)
Figure 35. Europe Neglected Tropical Diseases Drugs and Vaccine Sales and Growth Rate (2019-2025) & (K MT)
Figure 36. Europe Neglected Tropical Diseases Drugs and Vaccine Sales Market Share by Country in 2023
Figure 37. Germany Neglected Tropical Diseases Drugs and Vaccine Sales and Growth Rate (2019-2025) & (K MT)
Figure 38. France Neglected Tropical Diseases Drugs and Vaccine Sales and Growth Rate (2019-2025) & (K MT)
Figure 39. U.K. Neglected Tropical Diseases Drugs and Vaccine Sales and Growth Rate (2019-2025) & (K MT)
Figure 40. Italy Neglected Tropical Diseases Drugs and Vaccine Sales and Growth Rate (2019-2025) & (K MT)
Figure 41. Russia Neglected Tropical Diseases Drugs and Vaccine Sales and Growth Rate (2019-2025) & (K MT)
Figure 42. Asia Pacific Neglected Tropical Diseases Drugs and Vaccine Sales and Growth Rate (K MT)
Figure 43. Asia Pacific Neglected Tropical Diseases Drugs and Vaccine Sales Market Share by Region in 2023
Figure 44. China Neglected Tropical Diseases Drugs and Vaccine Sales and Growth Rate (2019-2025) & (K MT)
Figure 45. Japan Neglected Tropical Diseases Drugs and Vaccine Sales and Growth Rate (2019-2025) & (K MT)
Figure 46. South Korea Neglected Tropical Diseases Drugs and Vaccine Sales and Growth Rate (2019-2025) & (K MT)
Figure 47. India Neglected Tropical Diseases Drugs and Vaccine Sales and Growth Rate (2019-2025) & (K MT)
Figure 48. Southeast Asia Neglected Tropical Diseases Drugs and Vaccine Sales and Growth Rate (2019-2025) & (K MT)
Figure 49. South America Neglected Tropical Diseases Drugs and Vaccine Sales and Growth Rate (K MT)
Figure 50. South America Neglected Tropical Diseases Drugs and Vaccine Sales Market Share by Country in 2023
Figure 51. Brazil Neglected Tropical Diseases Drugs and Vaccine Sales and Growth Rate (2019-2025) & (K MT)
Figure 52. Argentina Neglected Tropical Diseases Drugs and Vaccine Sales and Growth Rate (2019-2025) & (K MT)
Figure 53. Columbia Neglected Tropical Diseases Drugs and Vaccine Sales and Growth Rate (2019-2025) & (K MT)
Figure 54. Middle East and Africa Neglected Tropical Diseases Drugs and Vaccine Sales and Growth Rate (K MT)
Figure 55. Middle East and Africa Neglected Tropical Diseases Drugs and Vaccine Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Neglected Tropical Diseases Drugs and Vaccine Sales and Growth Rate (2019-2025) & (K MT)
Figure 57. UAE Neglected Tropical Diseases Drugs and Vaccine Sales and Growth Rate (2019-2025) & (K MT)
Figure 58. Egypt Neglected Tropical Diseases Drugs and Vaccine Sales and Growth Rate (2019-2025) & (K MT)
Figure 59. Nigeria Neglected Tropical Diseases Drugs and Vaccine Sales and Growth Rate (2019-2025) & (K MT)
Figure 60. South Africa Neglected Tropical Diseases Drugs and Vaccine Sales and Growth Rate (2019-2025) & (K MT)
Figure 61. Global Neglected Tropical Diseases Drugs and Vaccine Production Market Share by Region (2019-2025)
Figure 62. North America Neglected Tropical Diseases Drugs and Vaccine Production (K MT) Growth Rate (2019-2025)
Figure 63. Europe Neglected Tropical Diseases Drugs and Vaccine Production (K MT) Growth Rate (2019-2025)
Figure 64. Japan Neglected Tropical Diseases Drugs and Vaccine Production (K MT) Growth Rate (2019-2025)
Figure 65. China Neglected Tropical Diseases Drugs and Vaccine Production (K MT) Growth Rate (2019-2025)
Figure 66. Global Neglected Tropical Diseases Drugs and Vaccine Sales Forecast by Volume (2019-2032) & (K MT)
Figure 67. Global Neglected Tropical Diseases Drugs and Vaccine Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global Neglected Tropical Diseases Drugs and Vaccine Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global Neglected Tropical Diseases Drugs and Vaccine Market Share Forecast by Type (2025-2032)
Figure 70. Global Neglected Tropical Diseases Drugs and Vaccine Sales Forecast by Application (2025-2032)
Figure 71. Global Neglected Tropical Diseases Drugs and Vaccine Market Share Forecast by Application (2025-2032)
